Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2018-07-30
Original market date: See footnote 1
1993-12-31
Product name:
DANTRIUM INTRAVENOUS
Description:
PWS 20MG/VIAL
DIN:
01997572
Product Monograph/Veterinary Labelling:
Date:
2018-04-23
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
ENDO PAR INNOVATION COMPANY, LLC
6 Ram Ridge Road
Chestnut Ridge
New York
United States
10977
Class:
Human
Dosage form(s):
Powder For Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
12:20.08
Anatomical Therapeutic Chemical (ATC): See footnote 4
M03CA01 DANTROLENE
Active ingredient group (AIG) number:See footnote5
0109855003
Active ingredient(s) | Strength |
---|---|
DANTROLENE SODIUM | 20 MG / VIAL |